Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call Transcript - Thomson StreetEvents

Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call Transcript

Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call Transcript - Thomson StreetEvents
Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call Transcript
Published Dec 06, 2021
Published Dec 06, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of FULC.OQ conference call or presentation 6-Dec-21 1:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Fulcrum Therapeutics Inc
Ticker
FULC.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Fulcrum Therapeutics Inc at Bank of America Healthcare Conference Transcript – 2022-05-12 – US$ 54.00 – Edited Transcript of FULC.OQ presentation 12-May-22 6:20pm GMT

Fulcrum Therapeutics Inc Q1 2022 Earnings Call Transcript – 2022-05-09 – US$ 54.00 – Edited Transcript of FULC.OQ earnings conference call or presentation 9-May-22 12:00pm GMT

Fulcrum Therapeutics Inc To Discuss Unmet Need In FSHD, REACH Trial And Key Measures Of Disease Progression Call Transcript – 2022-03-24 – US$ 54.00 – Edited Transcript of FULC.OQ conference call or presentation 24-Mar-22 2:00pm GMT

Fulcrum Therapeutics Inc Q4 2021 Earnings Call Transcript – 2022-03-03 – US$ 54.00 – Edited Transcript of FULC.OQ earnings conference call or presentation 3-Mar-22 1:00pm GMT

Fulcrum Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-13 – US$ 54.00 – Edited Transcript of FULC.OQ presentation 13-Jan-22 5:00pm GMT

Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript – 2021-11-11 – US$ 54.00 – Edited Transcript of FULC.OQ presentation 11-Nov-21 9:20pm GMT

Fulcrum Therapeutics Inc Q3 2021 Earnings Call Transcript – 2021-11-04 – US$ 54.00 – Edited Transcript of FULC.OQ earnings conference call or presentation 4-Nov-21 12:00pm GMT

Fulcrum Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of FULC.OQ presentation 9-Sep-21 8:15pm GMT

Fulcrum Therapeutics Inc Q2 2021 Earnings Call Transcript – 2021-08-10 – US$ 54.00 – Edited Transcript of FULC.OQ earnings conference call or presentation 10-Aug-21 12:00pm GMT

Fulcrum Therapeutics Inc Annual FSHD Society International Research Congress- Corporate Call Transcript – 2021-06-24 – US$ 54.00 – Edited Transcript of FULC.OQ conference call or presentation 24-Jun-21 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call Transcript" Dec 06, 2021. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Fulcrum-Therapeutics-Inc-To-Discuss-Phase-1-Clinical-Trial-of-FTX-6058-Call-T15067314>
  
APA:
Thomson StreetEvents. (2021). Fulcrum Therapeutics Inc To Discuss Phase 1 Clinical Trial of FTX-6058 Call Transcript Dec 06, 2021. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Fulcrum-Therapeutics-Inc-To-Discuss-Phase-1-Clinical-Trial-of-FTX-6058-Call-T15067314>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.